Navigation Links
Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2011 Financial Results
Date:11/8/2010

in the prior year period, at the high end of historical averages. Selling, marketing, general and administrative expenses for the Medical Products division increased to $6.4 million from $6.2 million in the second quarter of the prior year. The division had an income from operations before foreign exchange of $306,000 for the three months ended September 30, 2011, compared with a loss of $1.5 million in the prior year period.

Lipson added, "In the second quarter, we witnessed strong demand for our imaging products, despite systemic headwinds relating to temporary regulatory uncertainty, which we believe could be alleviated in the coming months. Strict attention to optimizing our purchase behavior helped drive profitability this quarter, in tandem with our revenue performance. We continue to take a long-term view that the medical device market in China is extremely compelling."

First Half Fiscal 2011 Financial ResultsDuring the first half of fiscal 2011, revenue increased 3.8% year over year to $86.7 million, compared to $83.5 million in the prior year. Revenue from the Healthcare Services division increased 11.9% to $48.1 million from $43.0 million in the first half of fiscal 2010. Revenue from the Medical Products division was $38.6 million, down 4.5% from $40.4 million in the prior year.

Income from operations remained flat at $6.6 million for the first half of fiscal 2011 as compared to the prior year period. Total operating costs and expenses for the fiscal year 2010 increased 4.0% to $79.9 million from $76.8 million in the prior year. This reflects $1.0 million of non-cash stock compensation expense compared to $1.5 million in the prior year period. Development, startup, and post-opening expenses in the Healthcare Services division were $1.1 million in the period compared to $642,000 in the prior year.

The Company recorded a $2.5 million provision for taxes, or an effective tax rate of 38.1%, in the first half of fiscal 2011, comp
'/>"/>

SOURCE Chindex International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Fosun Pharma Acquires $14 Million of Chindex Stock
2. Chindex International to Report First Quarter 2011 Financial Results
3. Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results
4. Chindex International to Report Third Quarter Fiscal Year 2010 Financial Results
5. Chindex International to Present at Piper Jaffray Health Care Conference
6. Chindex International Announces Participation in Brean Murray, Carret & Co. 2009 China Growth Conference
7. Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results
8. Chindex International, Inc. to Report Second Quarter Fiscal 2010 Financial Results
9. OXIS International, Inc. Announces Publication of Positive Results of Ergothioneine Safety Study in the Journal TOXICOLOGY
10. OXIS International, Inc. Announces Its Attendance at the Rodman & Renshaw Annual Global Investment Conference in London, May 16-18, 2010
11. Essilor Acquires FGX International, Becoming a Major Player in a New Fast-Growing Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD), a ... technologies and products for advanced microarray diagnostics, today ... Service Agreement to contract with a UK-based company ... the initial phase of this agreement, SQI will ... of one of the customer,s assays, operational on ...
(Date:8/21/2014)... --  Memorial Hermann Health System and The University ... new partnership to provide a new level of specialized breast ... the greater Houston area. ... provider of professional breast radiology services for five of Memorial ... The Woodlands , Northeast, Southwest and ...
(Date:8/21/2014)... Texas , Aug. 21, 2014  eRelevance ... services company, announced today that it has completed ... (EMR) solution for Plastic Surgery and Dermatology practices. ... even more value to healthcare practices using Nextech," ... of eRelevance Corporation. "Using information from the EMR ...
Breaking Medicine Technology:SQI Diagnostics Contracted to Automate Pathogen Detection Assays 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4eRelevance Corporation Integrates with Nextech Electronic Medical Records 2
(Date:8/22/2014)... August 22, 2014 The report ... Data Security & Compliance, Campus Technology, Student & ... Analysis (2014-2019)", defines and segments the global Higher ... analysis and forecasting of market sizes. The report ... restraints and opportunities impacting it along with the ...
(Date:8/22/2014)... Institutet in Sweden provides insight on how the brain ... from different sources and sides of the body, in ... which are presented in the journal Neuron , ... integrating various types of sensory information, with specialised functional ... is the main input structure in the basal ganglia, ...
(Date:8/22/2014)... New York University,s Langone Medical Center (NYULMC) heroically evacuating ... and most vulnerable down flights of stairs during the ... Hurricane Sandy. , Now, a recent study by ... (NYUCN) and of Dentistry (NYUCD), published in The ... NYULMC nurses, post-Sandy deployment to help address patient surge ...
(Date:8/22/2014)... 22, 2014 The ALS Association, along ... Center at Allegheny Health Network as a ... at Allegheny General Hospital (AGH), is the only ALS ... Association for meeting the highest levels of established national ... sclerosis (ALS), often referred to as Lou Gehrig’s Disease. ...
(Date:8/22/2014)... August 22, 2014 The New Jersey ... at Rutgers, the State University of New Jersey has ... children’s media organization, to educate young people about health ... on the strengths of both organizations. , The partnership ... health communications fellowship program, and video communications. ChopChop ...
Breaking Medicine News(10 mins):Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 4Health News:The striatum acts as hub for multisensory integration 2Health News:Study identifies challenges faced by NYU nurses after Hurricane Sandy 2Health News:Study identifies challenges faced by NYU nurses after Hurricane Sandy 3Health News:Allegheny Health Network ALS Program Named Certified Treatment Center of Excellence 2Health News:Allegheny Health Network ALS Program Named Certified Treatment Center of Excellence 3Health News:New Jersey Institute for Food, Nutrition & Health to Launch Innovative Partnership with Award-Winning Children’s Anti-Obesity Organization, ChopChop Kids 2Health News:New Jersey Institute for Food, Nutrition & Health to Launch Innovative Partnership with Award-Winning Children’s Anti-Obesity Organization, ChopChop Kids 3
... Calif., Jan. 6 Onyx Pharmaceuticals, Inc. (Nasdaq: ... to license rights to SB1518, an orally available, potent, and ... a JAK2 inhibitor, from S*BIO Pte Ltd based in Singapore. ... option rights to exclusively develop and commercialize SB1518 (designated by ...
... and SAN DIEGO, Jan. 6 BioMarin,Pharmaceutical Inc. (Nasdaq: ... LJPC ) announced today that they have ... Jolla,s investigational drug for,lupus nephritis, in the United States, ... Asia Pacific region. Following a successful Phase 3,trial, the ...
... wrist at 3T is an effective way to detect wrist ligament ... a study performed at Neuroskeletal Imaging in Merritt Island, Florida. ... and arthroscopy; 51 tears were found on arthroscopy. 41 of the ... 3T MRI is good. We are able to see the small ...
... shoulder allows physicians to better identify tears and provides ... not surgery is needed, according to a study performed ... The study included 150 patients who underwent both 3T ... did the study to see if MR, which is ...
... French . , Recent animal studies ... once used to treat diarrhea and other gastrointestinal disorders ... Huntington,s diseases. Scientists, however, had a variety of theories ... have such similar effects on three unrelated neurodegenerative disorders. ...
... (Nasdaq: WCRX ) today announced that it ... based in Korea, to develop and market their orally-administered ... the treatment of erectile dysfunction (ED) in the United ... of the product in the United States.Under the terms ...
Cached Medicine News:Health News:Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO 2Health News:Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO 3Health News:Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO 4Health News:BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent 2Health News:BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent 3Health News:BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent 4Health News:BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent 5Health News:BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent 6Health News:BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent 7Health News:BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent 8Health News:MR arthrography is more accurate than MR in diagnosing shoulder tears 2Health News:Old gastrointestinal drug slows aging, McGill researchers say 2Health News:Warner Chilcott and Dong-A Sign U.S. License Agreement For Erectile Dysfunction Treatment 2Health News:Warner Chilcott and Dong-A Sign U.S. License Agreement For Erectile Dysfunction Treatment 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: